Tuesday, 10 November 2026European Markets

LATECOERE Stock Tumbles 34% In 21 Sessions: Could This Be The Bottom?

Loading stream...
(vianews) - latecoere (cac 40: lat.pa) shares experienced a dramatic drop of 34.43% during 21 trading sessions, dropping from eur0.18 to eur0.12, as of 16:25 est monday. this decline occurred within the context of cac 40's overall upward trajectory - it currently sits at eur7,305.01 with an upward trend from prior trading sessions.

about latecoere

latecoere s.a. is an aerospace leader that specializes in designing, producing, assembling and installing aerostructures and interconnection systems for aircraft manufacturers worldwide. since we operate across europe, united states, africa and asia markets, as well as others internationally - catering to diverse customers from these regions - the company provides solutions that cater to every aspect of customer needs. aerostructures and interconnection systems segments ensure efficient production of aircraft components such as doors, wings, empennage and connecting rods. additionally, the company produces wing subassemblies and fuselage components, including tail cones, front fairings, watertight bulkheads and avionics racks. latecoere s.a. provides interconnection system components such as cameras, screens, data transmission solutions and other electronics for interconnection systems. established in 1917 and headquartered in toulouse france since then, latecoere is part of scp skn holding i sas as its subsidiary company.

technical analysis

latecoere, a french aerospace and electrical systems manufacturer, has seen its stock price steadily decline, currently hovering at eur20. along with this drop has come an equally dramatic decrease in trading volume; today's 12,462 shares traded represented a 27.52% drop from their average volume of 183,533. even with its decrease in volume, latecoere has seen relative stability in terms of short-term volatility; with an intraday variation average remaining positive at 1.95% and its highest average volatility amplitude being 4.25% last week; suggesting increased instability going forward. according to the stochastic oscillator, an influential technical indicator, latecoere stock is currently considered oversold (=20), suggesting it may be undervalued and due for an upward price movement in the near future. coupled with its relatively stable short-term volatility levels, this may present investors with an attractive investment opportunity with potential price appreciation potential in their portfolios.

equity analysis

losing money? latecoere has a trailing twelve-month earnings per share ratio of eur-0.18, signifying that over the past year it experienced losses totalling eur0.18 per share. when considering investing in companies reporting negative earnings, investors should take care when considering them as potential investments and analyze other metrics such as revenue growth, industry trends and management team to make an informed decision about investing. more news about latecoere (lat.pa).
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,558 source documents archived
Query this data → isubstrate.com